Pharmacytimes offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Thu, 22 Aug 19 17:49:21 +0000 Thu, 22 Aug 19 17:49:21 +0000 FDA Issues Warning Letter to OTC Drug Manufacturer For Data Integrity Concerns The FDA has published a warning letter sent to Ningbo Huize Commodity, an over-the-counter drug manufacturer, citing significant current good manufacturing practice (CGMP) violations including data integrity issues. Wed, 21 Aug 19 12:00:00 +0000 Survey: Customer Satisfaction With Pharmacists Remain High Despite e-commerce disruptions to the industry, a recent study found that the United States pharmacy industry continues to maintain high levels of customer satisfaction in both the brick-and-mortar and mail order segments.<br /> &nbsp; Tue, 20 Aug 19 20:18:00 +0000 ASHP to Recognize 2019 Zellmer Lecture Award Recipient Erin Fox, PharmD, BCPS, FASHP will be presenting the American Society of Health-System Pharmacists (ASHP) tenth annual William A. Zellmer Lecture on September 10, 2019, as recipient of the 2019 Zellmer Lecture Award. Tue, 20 Aug 19 19:51:00 +0000 Fun and Memorable Online Tools for Pharmacy Students Videos, podcasts, articles, and apps are readily available at our fingertips (literally) to help pharmacy students comprehend difficult subjects. Tue, 20 Aug 19 18:46:00 +0000 New Treatment for Rheumatoid Arthritis Granted FDA Approval Officials with the FDA have approved AbbVie&rsquo;s upadacitinib (Rinvoq) 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate (MTX-IR).&nbsp; Mon, 19 Aug 19 10:00:00 +0000 FDA Approves Pitolisant for Daytime Sleepiness in Patients with Narcolepsy The dug&nbsp;will be commercially available to healthcare professionals and appropriate patients in the U.S. in the fourth quarter of 2019. Thu, 15 Aug 19 21:10:00 +0000 Does Your Data Tell a Story: Translating Data Reporting in Specialty Pharmacy In an ideal world, how would you hypothesize that technology might be able to solve all of your problems?<br /> &nbsp; Mon, 12 Aug 19 13:08:00 +0000 New IV Connector Products Available These new Guarded Luer Connectors are used to join two luer lock syringes or other luer lock devices. Sat, 10 Aug 19 21:30:00 +0000 AACP Survey: 2019 Graduates Feel Prepared to Enter Practice As new pharmacists receive their exam results and enter the workforce, many are facing questions about their school experiences, career plans, further education plans, and the rising debt students face.&nbsp; Fri, 09 Aug 19 15:57:00 +0000 Scott Gottlieb to Serve as Keynote Speaker for the 37th Annual Chemotherapy Foundation Symposium Physicians&rsquo; Education Resource&reg; (PER&reg;), a worldwide leading resource for continuing medical education (CME), named public health expert and former commissioner of the Food and Drug Administration (FDA)&nbsp;Scott Gottlieb, M.D.,&nbsp;as the keynote speaker for the&nbsp;37th Annual&nbsp;Chemotherapy Foundation Symposium Innovative Cancer Therapy for Tomorrow.&reg; Thu, 08 Aug 19 20:16:00 +0000 Discover Pharmacy Camp Has High School Students Exploring the Profession High school students will explore pharmacy careers through activities such as extracting DNA from strawberries, and getting out of a pharmacy-themed escape room, during the upcoming Discover Pharmacy day camp, at Wilkes University. Thu, 08 Aug 19 14:00:00 +0000 Pharmacy, Public Health Associations Call for Action Against Gun Violence Pharmacy and public health associations have released statements following the recent shootings in California, Texas, and Ohio, and some are discussing what actions they can take to prevent further gun-related injury and death. Wed, 07 Aug 19 20:02:00 +0000 FDA Assessing Data Manipulation Concerns with Gene Therapy Product Officials with the FDA issued a statement to clarify data accuracy issues with recently-approved gene therapy Zolgensma (onasemnogene abeparvovec-xioi, AveXis), a product intended to treat spinal muscular atrophy (SMA) in children under 2 years old. Tue, 06 Aug 19 20:20:00 +0000 New Congress Offers Expert Evaluation of Latest Neurology Trends The 1st annual&nbsp;International Congress on the Future of Neurology&nbsp;will be held on September 27-28, 2019 in New York City, featuring a rigourous agenda of presentations, question and answer sessions, and lightning rounds highlighting topics across the breadth of neurology.&nbsp; Sat, 03 Aug 19 13:11:00 +0000 FDA Approves First Therapy for Adults with Rare TGCT Officials with the FDA have granted approval to pexidartinib (Turalio, Daiichi Sankyo) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive to improvement with surgery. Fri, 02 Aug 19 19:42:00 +0000 Overcoming Funding, Staffing Challenges Amid Rapid Growth in Health System Specialty Pharmacy With rapid growth, health system specialty pharmacies are more than likely to run into several operational pain points.<br /> &nbsp; Fri, 02 Aug 19 14:39:00 +0000 Can You Scale For It: Considerations in Health-System Specialty Pharmacy Growth With specialty pharmacy emerging as the fastest growing segment of the pharmacy industry, health systems have to address a key question: can you scale for it?<br /> &nbsp; Thu, 01 Aug 19 18:00:00 +0000 New Initiative Allows Pharmacists to Assist Patients with Copay Cards About 1000 patients are helped each month to reduce their costs for medications through the initiative. Thu, 01 Aug 19 15:00:00 +0000 Topical Treatment Options Expanded for Adolescents with Plaque Psoriasis Officials with the FDA have taken action on LEO Pharma&rsquo;s calcipotriene and betamethasone dipropionate foam and topical suspension products for the topical treatment of plaque psoriasis in patients age 12 years and older. Wed, 31 Jul 19 21:24:00 +0000 FDA Approves Darolutamide for Men with Non-Metastatic Castration-Resistant Prostate Cancer Darolutamide, an androgen receptor inhibitor (ARi) for the treatment of patients with non-metastatic castration-resistant prostate cancer, was approved by the FDA this week.<br /> &nbsp; Wed, 31 Jul 19 09:00:00 +0000 MJH Associates Forms Partnership with Hematology-Oncology Associates of Central New York The MJH SAP program partners Hematology-Oncology Associates of Central New York with&nbsp;Targeted Oncology&trade;,&nbsp;The American Journal of Managed Care&reg; and Pharmacy Times&reg;, Mon, 29 Jul 19 21:21:00 +0000 Mylan and Pfizer's Upjohn Division to Form New Combined Company Mylan and Pfizer have announced an agreement to combine Mylan with Upjohn, Pfizer&rsquo;s off-patent branded and generic established medicines business.&nbsp;<br /> &nbsp; Mon, 29 Jul 19 18:00:00 +0000 Scan Technique Shows Brain Inflammation in Posttreatment Lyme Disease Syndrome In a study by Johns Hopkins Medicine, investigators used an advanced form of brain scan to demonstrate that 12 participants in their study with documented posttreatment Lyme disease syndrom (PTLDS) all showed elevation of a chemical marker of wide-spread brain inflammation compared with 19 controls. Sat, 27 Jul 19 18:00:00 +0000 Nasal Powder Glucagon Receives FDA Approval The FDA has granted Eli Lilly and Company approval for its nasal powder glucagon (Baqsimi) for emergency treatment of severe hypoglycemia.<br /> &nbsp; Thu, 25 Jul 19 20:21:00 +0000 Parasitic Deer Fly Population Spreads Across United States A species of deer parasites known as deer keds, or&nbsp;<em>Lipoptena cervi</em>, is more widely distributed across the United States than previously thought, according to Pennsylvania State University entomologists, who noted the parasites&#39; potential to transmit disease-causing bacteria. Thu, 25 Jul 19 09:00:00 +0000